72 related articles for article (PubMed ID: 8280192)
1. Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs.
Richardson GE; Venzon DJ; Edison M; Brown M; Frame JN; Ihde DC; Johnson BE
Arch Intern Med; 1993 Feb; 153(3):329-37. PubMed ID: 8280192
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the costs of paclitaxel and best supportive care in stage IV non-small-cell lung cancer.
Earle CC; Evans WK
Cancer Prev Control; 1997 Oct; 1(4):282-8. PubMed ID: 9765752
[TBL] [Abstract][Full Text] [Related]
4. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
[TBL] [Abstract][Full Text] [Related]
6. Metastatic non-small cell lung cancer: costs associated with disease progression.
Fox KM; Brooks JM; Kim J
Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
[TBL] [Abstract][Full Text] [Related]
7. Staging in untreated patients with small cell lung cancer.
Vrdoljak E; Mise K; Sapunar D; Rozga A; Marusic M
Neoplasma; 2001; 48(2):154-6. PubMed ID: 11478698
[TBL] [Abstract][Full Text] [Related]
8. A pharmacoeconomic evaluation of cisplatin in combination with either etoposide or etoposide phosphate in small cell lung cancer.
Doyle JJ; Dezii CM; Sadana A
Semin Oncol; 1996 Dec; 23(6 Suppl 13):51-60. PubMed ID: 8996576
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
11. Sequential staging systems for small-cell lung cancer.
Chauvin F; Trillet-Lenoir V; Cordier JF
Arch Intern Med; 1993 Oct; 153(19):2277. PubMed ID: 8215731
[No Abstract] [Full Text] [Related]
12. Cost-effectivenes of paclitaxel plus cisplatin in advanced non-small-cell lung cancer.
Earle CC; Evans WK
Br J Cancer; 1999 May; 80(5-6):815-20. PubMed ID: 10360660
[TBL] [Abstract][Full Text] [Related]
13. Practical issues in the management of the patient with small cell lung cancer.
Govindan R; Ihde DC
Chest Surg Clin N Am; 1997 Feb; 7(1):167-81. PubMed ID: 9001763
[TBL] [Abstract][Full Text] [Related]
14. Staging of the patient with small cell lung cancer.
Darling GE
Chest Surg Clin N Am; 1997 Feb; 7(1):81-94. PubMed ID: 9001757
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and lung cancer clinical trials.
Du W; Reeves JH; Gadgeel S; Abrams J; Peters WP
Cancer; 2003 Oct; 98(7):1491-6. PubMed ID: 14508837
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.
Ng R; Hasan B; Mittmann N; Florescu M; Shepherd FA; Ding K; Butts CA; Cormier Y; Darling G; Goss GD; Inculet R; Seymour L; Winton TL; Evans WK; Leighl NB; ; ;
J Clin Oncol; 2007 Jun; 25(16):2256-61. PubMed ID: 17538170
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of a test to detect metastases for endometrial cancer.
Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
[TBL] [Abstract][Full Text] [Related]
19. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer.
Yasufuku K; Chiyo M; Koh E; Moriya Y; Iyoda A; Sekine Y; Shibuya K; Iizasa T; Fujisawa T
Lung Cancer; 2005 Dec; 50(3):347-54. PubMed ID: 16171897
[TBL] [Abstract][Full Text] [Related]
20. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
